MedPath

Comprehensive Study of Social Representation of Platelet Transfusion in Patients Followed for Advanced Hematological Malignancies (R-PLQ)

Completed
Conditions
Hematological Malignancy
Palliative Care
Platelet Transfusion
Registration Number
NCT03806712
Lead Sponsor
Centre Hospitalier Universitaire de Besancon
Brief Summary

Limited data is available for end of life care in hematologic malignancies, moreover with thrombocytopenic patients. Thrombopenia is a frequent complication, specific of bone marrow involvement in those diseases or its treatments. Yet, a few studies was interested in, whereas platelet transfusion is the only treatment indicated. As it represent a scarce, limited resource, the ethical principles are in conflict in this setting and there's a lack of recommendation. The final decision is take by the clinician and his patient, but no study exist in representation of the two parts. We provide a qualitative study to understand what this decision is made of.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
45
Inclusion Criteria
  • major patient
  • patient with advanced hematological malignancies
  • patient transfused in platelet regularly (3 time at least in last month)
  • medical practioner, hematologist, prescribing platelet transfusion at least one per week.
  • nurse working in hematology, practicing platelet transfusion at lest one peer week.
Exclusion Criteria
  • minor patient
  • non communicant patient
  • non transfused platelet patient
  • non voluntary patient or hematologist or nurses
  • non graduated hematologist

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
measure the impact of social representation on platelet transfusion practice3 months

inner core and peripheral items of platelet transfusion of each participant will be collected until reaching saturation, it's to say that the repetition of some terms will be measured between each interview thank's to a questionnaire of at least two principals opened questions.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Moracchini

🇫🇷

Besançon, France

Moracchini
🇫🇷Besançon, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.